Human CD229 PharmaGenie ELISA Kit (SBRS0369)

The Assay Genie Human CD229 PharmaGenie ELISA Kit enables quantitative measurement of CD229, also known as SLAMF3 or Ly9, a member of the signaling lymphocytic activation molecule receptor family expressed on T and B lymphocytes. The immunoassay supports research into lymphocyte activation, immune synapse formation, and autoimmune disease mechanisms where SLAM-family signaling is implicated. Researchers use the kit to analyze cell culture supernatants and matched biofluid specimens collected under standard in vitro laboratory protocols. Each microplate-based kit is configured for 96 determinations and includes all reagents intended for research use only, with handling recommendations including refrigeration of components and protection from light to preserve antibody activity. Capture and detection antibodies are paired against human CD229 epitopes, providing human-specific detection with no significant cross-reactivity with rodent homologues, making it a reproducible tool for immunology, vaccine research, and biomarker discovery workflows.